BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 27047774)

  • 1. Hepatitis C Virus, Insulin Resistance, and Steatosis.
    Kralj D; Virović Jukić L; Stojsavljević S; Duvnjak M; Smolić M; Čurčić IB
    J Clin Transl Hepatol; 2016 Mar; 4(1):66-75. PubMed ID: 27047774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between hepatitis C virus and metabolic factors.
    Kawaguchi Y; Mizuta T
    World J Gastroenterol; 2014 Mar; 20(11):2888-901. PubMed ID: 24659880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steatosis and insulin resistance in hepatitis C: a way out for the virus?
    Del Campo JA; Romero-Gómez M
    World J Gastroenterol; 2009 Oct; 15(40):5014-9. PubMed ID: 19859993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes.
    Mihm S
    Dig Dis; 2010; 28(1):280-4. PubMed ID: 20460924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.
    Vespasiani-Gentilucci U; Gallo P; De Vincentis A; Galati G; Picardi A
    World J Gastroenterol; 2014 Mar; 20(11):2825-38. PubMed ID: 24659875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis C virus-associated and metabolic steatosis. Different or overlapping diseases?].
    Lonardo A; Loria P; Adinolfi LE; Andreana A; Ruggiero G; Carulli N
    Ann Ital Med Int; 2005; 20(1):10-22. PubMed ID: 15859390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease and hepatitis C infection.
    Bondini S; Younossi ZM
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of steatosis in hepatitis C virus infection.
    Adinolfi LE; Restivo L; Marrone A
    Expert Rev Gastroenterol Hepatol; 2013 Mar; 7(3):205-13. PubMed ID: 23445230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations.
    Adinolfi LE; Rinaldi L; Guerrera B; Restivo L; Marrone A; Giordano M; Zampino R
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
    Serfaty L; Capeau J
    Liver Int; 2009 Mar; 29 Suppl 2():13-25. PubMed ID: 19187069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms and significance of liver steatosis in hepatitis C virus infection.
    Negro F
    World J Gastroenterol; 2006 Nov; 12(42):6756-65. PubMed ID: 17106922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and liver steatosis in chronic hepatitis C infection genotype 3.
    Abenavoli L; Masarone M; Peta V; Milic N; Kobyliak N; Rouabhia S; Persico M
    World J Gastroenterol; 2014 Nov; 20(41):15233-40. PubMed ID: 25386071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C.
    Castera L
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):125-34. PubMed ID: 16557184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and steatosis in chronic hepatitis C.
    Machado MV; Cortez-Pinto H
    Ann Hepatol; 2009; 8 Suppl 1():S67-75. PubMed ID: 19381127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C Virus-Lipid Interplay: Pathogenesis and Clinical Impact.
    Elgretli W; Chen T; Kronfli N; Sebastiani G
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hepatitis C virus infection: a new modifiable cardio-metabolic risk factor?
    Cuciureanu T; Chiriac S; Chiorescu M; Gîrleanu I; Trifan A
    Clujul Med; 2017; 90(3):251-255. PubMed ID: 28781519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance, steatosis and hepatitis C virus.
    Mangia A; Ripoli M
    Hepatol Int; 2013 Dec; 7 Suppl 2(Suppl 2):782-9. PubMed ID: 24587848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic alterations and hepatitis C: From bench to bedside.
    Chang ML
    World J Gastroenterol; 2016 Jan; 22(4):1461-76. PubMed ID: 26819514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C as a metabolic disease: Implication for the pathogenesis of NASH.
    Koike K
    Hepatol Res; 2005 Oct; 33(2):145-50. PubMed ID: 16202646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.
    Halfon P; Pénaranda G; Carrat F; Bedossa P; Bourlière M; Ouzan D; Renou C; Tran A; Rosenthal E; Wartelle C; Delasalle P; Cacoub P
    Aliment Pharmacol Ther; 2009 Jul; 30(1):61-70. PubMed ID: 19292832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.